CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a new modeling framework to predict how drugs dissolve from tablets, addressing quality issues in pharmaceutical manufacturing. By integrating various modeling techniques, it aims to shorten the drug development cycle and improve the reliability of medication.
The European pharmaceutical market is worth more than 200 billion euros, and a significant share of it comes from tablets, the most popular dosage form used to treat hundreds of millions of patients.
The in vitro dissolution profile is used to characterize how the drug is released from tablets, indicating their effectiveness.
However, an incomplete understanding of the effect of material attributes and process parameters on the dissolution profile of tablets has been the source of various qualit…
UNIVERSITY OF LEICESTER
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, FOREST ROW
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.